These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 27745762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.
    Higashi Y.
    Int J Urol; 2017 Jun; 24(6):412-424. PubMed ID: 28332240
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Erectile Dysfunction and Lower Urinary Tract Symptoms.
    De Nunzio C, Roehrborn CG, Andersson KE, McVary KT.
    Eur Urol Focus; 2017 Oct; 3(4-5):352-363. PubMed ID: 29191671
    [Abstract] [Full Text] [Related]

  • 7. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
    Glina S, Roehrborn CG, Esen A, Plekhanov A, Sorsaburu S, Henneges C, Büttner H, Viktrup L.
    J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
    [Abstract] [Full Text] [Related]

  • 8. Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.
    Kardasevic A, Milicevic S.
    Med Arch; 2017 Feb; 71(1):32-36. PubMed ID: 28428671
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
    Russo GI, Cimino S, Fragalà E, Privitera S, La Vignera S, Condorelli R, Calogero AE, Castelli T, Favilla V, Morgia G.
    J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.
    Mirone V, Sessa A, Giuliano F, Berges R, Kirby M, Moncada I.
    Int J Clin Pract; 2011 Sep; 65(9):1005-13. PubMed ID: 21718399
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of metabolic syndrome and its association with lower urinary tract symptoms and sexual function.
    Plata M, Caicedo JI, Trujillo CG, Mariño-Alvarez ÁM, Fernandez N, Gutierrez A, Godoy F, Cabrera M, Cataño-Cataño JG, Robledo D.
    Actas Urol Esp; 2017 Oct; 41(8):522-528. PubMed ID: 28390836
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?
    Shimizu S, Tsounapi P, Shimizu T, Honda M, Inoue K, Dimitriadis F, Saito M.
    Int J Urol; 2014 Sep; 21(9):856-64. PubMed ID: 24930630
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction.
    Calogero AE, Burgio G, Condorelli RA, Cannarella R, La Vignera S.
    Aging Male; 2019 Mar; 22(1):12-19. PubMed ID: 29392976
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.